1 - 25 of
60
results
for author:"Ichikawa Y."
in Literature Citations
| Identification of Cystatin SN as a novel tumor marker for colorectal cancer. Yoneda K., Iida H., Endo H., Hosono K., Akiyama T., Takahashi H., Inamori M., Abe Y., Yoneda M., Fujita K. et al. Int. J. Oncol. 35:33-40(2009) · Mapped (1) |
| The proangiogenic factor ephrin-A1 is up-regulated in radioresistant murine tumor by irradiation. Nojiri K., Iwakawa M., Ichikawa Y., Imadome K., Sakai M., Nakawatari M., Ishikawa K., Ishikawa A., Togo S., Tsujii H. et al. Exp. Biol. Med. (Maywood) 234:112-122(2009) · Mapped (2) |
| Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer. Takagawa R., Fujii S., Ohta M., Nagano Y., Kunisaki C., Yamagishi S., Osada S., Ichikawa Y., Shimada H. Ann. Surg. Oncol. 15:3433-3439(2008) · Mapped (7) |
| Virological and serological studies of porcine respiratory coronavirus infection on a Japanese farm. Usami Y., Fukai K., Ichikawa Y., Okuda Y., Shibata I., Motoyama C., Imai K., Kirisawa R. J. Vet. Med. Sci. 70:929-936(2008) · UniProtKB (4) |
| Rapid screening assay for KRAS mutations by the modified smart amplification process. Tatsumi K., Mitani Y., Watanabe J., Takakura H., Hoshi K., Kawai Y., Kikuchi T., Kogo Y., Oguchi-Katayama A., Tomaru Y. et al. J Mol Diagn 10:520-526(2008) · Mapped (8) |
| Molecular epidemiological and mutational analysis of DNA mismatch repair (MMR) genes in endometrial cancer patients with HNPCC-associated familial predisposition to cancer. Hirai Y., Banno K., Suzuki M., Ichikawa Y., Udagawa Y., Sugano K., Miki Y. Cancer Sci. 99:1715-1719(2008) · Mapped (49) |
| The overexpression and altered localization of the atypical protein kinase C lambda/iota in breast cancer correlates with the pathologic type of these tumors. Kojima Y., Akimoto K., Nagashima Y., Ishiguro H., Shirai S., Chishima T., Ichikawa Y., Ishikawa T., Sasaki T., Kubota Y. et al. Hum. Pathol. 39:824-831(2008) · Mapped (3) |
| Novel SIL1 mutations and exclusion of functional candidate genes in Marinesco-Sjogren syndrome. Anttonen A.K., Siintola E., Tranebjaerg L., Iwata N.K., Bijlsma E.K., Meguro H., Ichikawa Y., Goto J., Kopra O., Lehesjoki A.E. Eur. J. Hum. Genet. 16:961-969(2008) · Mapped (3) |
| The sugar-binding ability of ERGIC-53 is enhanced by its interaction with MCFD2. Kawasaki N., Ichikawa Y., Matsuo I., Totani K., Matsumoto N., Ito Y., Yamamoto K. Blood 111:1972-1979(2008) · Mapped (10) |
| Hepatocyte growth factor and interleukin-6 in combination with prostate volume are possible prostate cancer tumor markers in patients with gray-zone PSA levels. Nishimura K., Arichi N., Tokugawa S., Yoshioka I., Namba Y., Kishikawa H., Takahara S., Ichikawa Y. Prostate Cancer Prostatic Dis. 11:258-263(2008) · Mapped (9) |
| Correlating purity by microdissection with gene expression in gastric cancer tissue. Otsuka Y., Ichikawa Y., Kunisaki C., Matsuda G., Akiyama H., Nomura M., Togo S., Hayashizaki Y., Shimada H. Scand. J. Clin. Lab. Invest. 67:367-379(2007) · Mapped (1) |
| EGFR mutation of tumor and serum in gefitinib-treated patients with chemotherapy-naive non-small cell lung cancer. Kimura H., Kasahara K., Shibata K., Sone T., Yoshimoto A., Kita T., Ichikawa Y., Waseda Y., Watanabe K., Shiarasaki H. et al. J Thorac Oncol 1:260-267(2006) · Mapped (15) |
| The proteasome activator PA28 functions in collaboration with Hsp90 in vivo. Minami M., Shinozaki F., Suzuki M., Yoshimatsu K., Ichikawa Y., Minami Y. Biochem. Biophys. Res. Commun. 344:1315-1319(2006) · Mapped (3) |
| Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response. Matsuyama R., Togo S., Shimizu D., Momiyama N., Ishikawa T., Ichikawa Y., Endo I., Kunisaki C., Suzuki H., Hayasizaki Y. et al. Int. J. Cancer 119:406-413(2006) · UniProtKB (1) |
| The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway. Ozawa T., Araki N., Yunoue S., Tokuo H., Feng L., Patrakitkomjorn S., Hara T., Ichikawa Y., Matsumoto K., Fujii K. et al. J. Biol. Chem. 280:39524-39533(2005) · Mapped (10) |
| The epidermal stem cell factor is over-expressed in lentigo senilis: implication for the mechanism of hyperpigmentation. Hattori H., Kawashima M., Ichikawa Y., Imokawa G. J. Invest. Dermatol. 122:1256-1265(2004) · Mapped (1) |
| Evaluation of 9.4-T MR microimaging in assessing normal and defective fetal bone development: comparison of MR imaging and histological findings. Ichikawa Y., Sumi M., Ohwatari N., Komori T., Sumi T., Shibata H., Furuichi T., Yamaguchi A., Nakamura T. Bone 34:619-628(2004) · Mapped (5) |
| Galectin-1 induces cell adhesion to the extracellular matrix and apoptosis of non-adherent human colon cancer Colo201 cells. Horiguchi N., Arimoto K., Mizutani A., Endo-Ichikawa Y., Nakada H., Taketani S. J. Biochem. 134:869-874(2003) · Mapped (3) |
| Overexpression of P104L mutant caveolin-3 in mice develops hypertrophic cardiomyopathy with enhanced contractility in association with increased endothelial nitric oxide synthase activity. Ohsawa Y., Toko H., Katsura M., Morimoto K., Yamada H., Ichikawa Y., Murakami T., Ohkuma S., Komuro I., Sunada Y. Hum. Mol. Genet. 13:151-157(2004) · Mapped (9) |
| Electrostatic guidance of glycosyl cation migration along the reaction coordinate of uracil DNA glycosylase. Bianchet M.A., Seiple L.A., Jiang Y.L., Ichikawa Y., Amzel L.M., Stivers J.T. Biochemistry 42:12455-12460(2003) · Mapped (4) |
| T cell-specific disruption of arylhydrocarbon receptor nuclear translocator (Arnt) gene causes resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced thymic involution. Tomita S., Jiang H.B., Ueno T., Takagi S., Tohi K., Maekawa S., Miyatake A., Furukawa A., Gonzalez F.J., Takeda J. et al. J. Immunol. 171:4113-4120(2003) · Mapped (7) |
| Expression of constitutively activated EGFRvIII in non-small cell lung cancer. Okamoto I., Kenyon L.C., Emlet D.R., Mori T., Sasaki J., Hirosako S., Ichikawa Y., Kishi H., Godwin A.K., Yoshioka M. et al. Cancer Sci. 94:50-56(2003) · Mapped (15) |
| The genome sequence and structure of rice chromosome 1. Sasaki T., Matsumoto T., Yamamoto K., Sakata K., Baba T., Katayose Y., Wu J., Niimura Y., Cheng Z., Nagamura Y. et al. Nature 420:312-316(2002) · UniProtKB (7,287) |
| Mechanism of the Escherichia coli ADP-ribose pyrophosphatase, a Nudix hydrolase. Gabelli S.B., Bianchet M.A., Ohnishi Y., Ichikawa Y., Bessman M.J., Amzel L.M. Biochemistry 41:9279-9285(2002) · UniProtKB (1) · Mapped (3) |
| Inactivation of p16/CDKN2 and p15/MTS2 is associated with prognosis and response to chemotherapy in ovarian cancer. Kudoh K., Ichikawa Y., Yoshida S., Hirai M., Kikuchi Y., Nagata I., Miwa M., Uchida K. Int. J. Cancer 99:579-582(2002) · Mapped (13) |
